News

EVERY Company Secures Funding to Boost US Protein Manufacturing

EVERY Company Secures Funding to Boost US Protein Manufacturing

Significant Investment in Domestic Protein Production

The EVERY Company, a pioneer in producing innovative protein ingredients, has recently received a remarkable $2 million grant from the US Department of Defense. This funding is specifically aimed at assessing the feasibility of establishing a manufacturing site within the US, a significant step towards boosting domestic biomanufacturing capabilities.

Exploring New Horizons in Protein Innovation

The financial support will facilitate a thorough evaluation of manufacturing sites for EVERY’s two primary proteins. These proteins include a highly soluble formulation focused on boosting protein content in various foods and ovalbumin, which serves as a functional substitute for traditional egg and egg whites, currently protected by a foundational patent.

Contributing to National Security Initiatives

This grant is part of the Distributed Bioindustrial Manufacturing Program initiated by the DoD, which underscores the importance of enhancing US biomanufacturing in critical sectors: fabrication, firepower, fitness, food, and fuel. Arturo Elizondo, the CEO of EVERY, emphasized the potential of this investment to solidify domestic supply chains, reduce dependency on imports, and position the United States as a frontrunner in food technology amidst the challenges posed by food insecurity and climate change.

Military Applications of Advanced Proteins

In alignment with the funding's objectives, EVERY intends to develop military applications for its proprietary proteins. One notable application involves utilizing its soluble protein to create high-quality nutritional solutions presented in compact formats. The technology behind this protein allows it to yield impressive results, such as a protein-enriched drink that has the appearance and flavor of plain water while delivering substantial protein nutrition.

Expanding Production Capacity

EVERY has consistently demonstrated its production process at an industrial scale over 100,000 liters, successfully obtaining FDA approval for all products. With ambitions to enter the mass market over the next year, Elizondo noted that many client demands require vast quantities of protein. The funding from the Department of Defense will significantly aid in ramping up production capacities to satisfy these growing requirements.

Environmental Benefits and Economic Contributions

Beyond the direct impact on protein production, EVERY’s methodology significantly conserves land and water resources compared to conventional protein production methods. By leveraging US-grown corn as the primary feedstock, EVERY also actively supports local rural economies, reinforcing the positive cycle of local agricultural health and sustainability.

Recent Innovations and Partnerships

This achievement follows a recent announcement in which EVERY secured a pioneering patent for ovalbumin, broadening its application spectrum. Additionally, EVERY has forged partnerships with global brands, enhancing its portfolio and market reach. Collaborative agreements with influential companies such as Grupo Nutresa, Colombia’s foremost food enterprise, and Grupo Palacios, recognized worldwide for producing Spanish omelets, demonstrate EVERY's expansive industry connections.

Another notable collaboration includes the Unilever brand, the Vegetarian Butcher, which further highlights EVERY's innovative approaches and market adaptability.

About EVERY™

EVERY™ is a cutting-edge food technology enterprise based in San Francisco. Their mission revolves around establishing a more secure and accessible global food system, providing food and beverage companies with bio-identical protein ingredients crafted through precision fermentation. Among the innovative ingredients offered are OvoPro™ and OvoBoost™, both of which are FDA-approved and cater to a wide array of food applications, enhancing nutritional value across multiple markets.

Frequently Asked Questions

What is the purpose of the $2M grant awarded to EVERY?

The grant is aimed at assessing the feasibility of establishing a US-based manufacturing facility for EVERY's protein products.

What proteins are being developed by EVERY?

EVERY is focusing on a highly soluble protein for food fortification and ovalbumin, which replaces traditional egg ingredients.

How does this funding relate to national security?

The funding is part of a program aimed at enhancing domestic biomanufacturing, reducing reliance on foreign imports, and ensuring food security.

What unique applications does EVERY’s protein technology offer?

The technology allows for high-quality nutrient delivery in formats that are convenient and appealing, such as protein-enriched beverages.

What are the environmental advantages of EVERY's production methods?

EVERY’s process uses significantly less land and water than conventional protein production, while supporting local agricultural economies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 2

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 4

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 3

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 2

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 3

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 4

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 1

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Defense Modifies Warrants and Engages New Marketing Team

Updated Category News Views 109

Liberty Defense Informs Investors of Significant Changes Liberty Defense Holdings Ltd. is making headlines with its recent announcement regarding the repricing of outstanding warrants and the establishment of a marketing contract. Liberty is recognized as a leading technology provider specializing in AI-based detection solutions aimed at enhancing security through...

Continue Reading
IMF Advocates Sustained Tight Monetary Policy in Turkey

Updated Category News Views 161

IMF's Recommendations for Turkey's Monetary Policy The International Monetary Fund (IMF) has strongly advised that Turkey maintain a tight, data-driven monetary policy until the nation’s inflation rate aligns with its established target. This conclusion comes after the completion of an Article IV consultation, highlighting the importance of stable economic practices....

Continue Reading
InterDigital Celebrates Win at Fierce Network Innovation Awards

Updated Category News Views 105

InterDigital Receives Recognition for AI Innovations InterDigital, Inc. (NASDAQ: IDCC), a leader in mobile, video, and AI technology research, has recently been honored with a prestigious award for its exceptional advancements in artificial intelligence. The Fierce Network Innovation Award, announced at a notable event, highlights innovations that have the potential to...

Continue Reading
CVS Health Announces Dividend and Strategic Developments

Updated Category News Views 60

CVS Health Announces Quarterly Dividend CVS Health Corporation (NYSE: CVS) has just declared a quarterly dividend of $0.665 per share on its Common Stock. This decision, made by the company's board of directors, highlights CVS's commitment to returning value to its shareholders. The dividend payment is scheduled for a future date, allowing stockholders on record to...

Continue Reading
Bruker Unveils Innovative Dimension Nexus™ AFM for Research

Updated Category News Views 131

Bruker Unveils the Dimension Nexus™ Atomic Force Microscope Bruker Corporation (Nasdaq: BRKR) has proudly announced the introduction of the Dimension Nexus™ atomic force microscope (AFM). This revolutionary instrument is set to enhance the capabilities of research labs around the world, offering a sophisticated yet compact solution for advanced imaging and analysis....

Continue Reading